Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics [Internet]. 2017 May 1 [cited 2024 May 4];72(5):317-24. Available from: https://revistas.usp.br/clinics/article/view/133343